Steffie K. Naber

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies

Amy B. Knudsen, Ann G. Zauber, Carolyn M. Rutter et al. · JAMA · 2016 · 481 citations · Full text

Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries

Steffie K. Naber, Amy B. Knudsen, Ann G. Zauber et al. · PLoS ONE · 2019 · 67 citations · Full text

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates

Kirsten Rozemeijer, Corine Penning, Albert G. Siebers et al. · Cancer Causes & Control · 2015 · 61 citations · Full text

Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential

Steffie K. Naber, Suman Kundu, Karen M. Kuntz et al. · JNCI Cancer Spectrum · 2019 · 59 citations · Full text

Offering Self-Sampling to Non-Attendees of Organized Primary HPV Screening: When Do Harms Outweigh the Benefits?

Kirsten Rozemeijer, Inge M.C.M. de Kok, Steffie K. Naber et al. · Cancer Epidemiology Biomarkers & Prevention · 2014 · 49 citations · Full text